Risk factors for infection/colonization caused by resistant Gram negative bacilli in critically ill patients (An observational study of 1633 critically ill patients)

Preventive Medicine

Volumn 57, Issue SUPPL, 2013, Pages

  Vasudevan, Anupama ^a   Mukhopadhyay, Amartya ^a   Goh, Eugene Yu Yuen ^a   Li, Jialiang ^b   Tambyah, Paul Ananth ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Broad spectrum antibiotics; Critically Ill; ICU; Resistant Gram negative bacilli; Risk factors

Indexed keywords

CARBAPENEM; LINEZOLID; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; COHORT ANALYSIS; COMORBIDITY; CRITICALLY ILL PATIENT; FEMALE; GRAM NEGATIVE INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SINGAPORE;

BROAD SPECTRUM ANTIBIOTICS; CENTRAL VENOUS CATHETER; CRITICALLY ILL; CVC; ESBL; EXTENDED SPECTRUM BETA LACTAMASE; ICU; IDSA; INFECTIOUS DISEASES SOCIETY OF AMERICA; INTENSIVE CARE UNIT; MDR; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MRSA; MULTI-DRUG RESISTANCE; RESISTANT GRAM NEGATIVE BACILLI; RGNB; RISK FACTORS; SGNB; SUSCEPTIBLE GRAM NEGATIVE BACILLI;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE;

EID: 84880612567     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2012.12.003     Document Type: Article

References (20)

1. Akinci E., Colpan A., Bodur H., Balaban N., Erbay A. Risk factors for ICU-acquired imipenem-resistant Gram-negative bacterial infections. J. Hosp. Infect. 2005, 59:317-323.
2. Anunnatsiri S., Tonsawan P. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand. Southeast Asian J. Trop. Med. Public Health 2011, 42:693-703.
3. Boucher H.W., Talbot G.H., Bradley J.S., et al. Bad Bugs, No Drugs: No ESKAPE! an update from the Infectious Diseases Society of America. Clin. Infect. Dis. 2009, 48:1-12.
4. Bouchillon S.K., Iredell J.R., Barkham T., Lee K., Dowzicky M.J. Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST). Int. J. Antimicrob. Agents 2009, 33:130-136.
5. Cisneros J.M., Rodríguez-Baño J., Fernández-Cuenca F., et al. Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin. Microbiol. Infect. 2005, 11:874-879.
6. Cohen A.L., Calfee D., Fridkin S.K., et al. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper. Infect. Control Hosp. Epidemiol. 2008, 29:901-913.
7. Demirdag K., Hosoglu S. Epidemiology and risk factors for ESBL-producing Klebsiella pneumoniae: a case control study. J. Infect. Dev. Ctries. 2010, 4:717-722.
8. Donaldson A.D., Razak L., Liang L.J., Fisher D.A., Tambyah P.A. Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter?. Int. J. Antimicrob. Agents 2009, 34:246-251.
9. European Centre for Disease Prevention and Control EARSS Annual Report 2008. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2009.
10. Gaynes R., Edwards J.R. National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by Gram-negative bacilli. Clin. Infect. Dis. 2005, 41:848-854.2.
11. Hosmer D.L.S. Applied logistic regression. Wiley Series in Probability and Mathematical Statistics, New York 1989, 2nd ed.
12. Jeon M.H., Choi S.H., Kwak Y.G., et al. Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients. Diagn. Microbiol. Infect. Dis. 2008, 62:402-406.
13. Kang C.I., Kim S.H., Park W.B., et al. Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa. Microb. Drug Resist. 2005, 11:68-74.
14. Ortega B., Groeneveld A.B.J., Schultsz C. Endemic multidrug-resistant Pseudomonas aeruginosa in critically ill patients. Infect. Control Hosp. Epidemiol. 2004, 25:825-831.
15. Raymond D.P., Pelletier S.J., Crabtree T.D., Evans H.L., Pruett T.L., Sawyer R.G. Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients. Crit. Care Med. 2003, 31:1035-1041.
16. Rosenthal V.D., Maki D.G., Mehta A., et al. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am. J. Infect. Control 2008, 36:627-637.
17. Surasarang K., Narksawat K., Danchaivijitr S., et al. Risk factors for multi-drug resistant Acinetobacter baumannii nosocomial infection. J. Med. Assoc. Thai. 2007, 90:1633-1639.
18. Teng C.B., Lee W., Yeo C.L., et al. Guidelines for antimicrobial stewardship training and practice. Ann. Acad. Med. Singapore 2012, 41:29-34.
19. Terpenning M.S., Bradley S.F., Wan J.Y., Chenoweth C.E., Jorgensen K.A., Kauffman C.A. Colonization and infection with antibiotic-resistant bacteria in a long-term care facility. J Am Geriatr Soc. 1994, 42:1062-1069.
20. Varley A.J., Williams H., Fletcher S. Antibiotic resistance in the intensive care unit. CEACCP 2009, 9:114-118.